DOCSLIB.ORG

JUD Committee Hearing Transcript for 03/22/2019

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
JUD Committee Hearing Transcript for 03/22/2019 1 MARCH 22, 2019 LRN JUDICIARY COMMITTEE 10:00 A.M. PUBLIC HEARING CHAIRPERSON: Senator Gary Winfield, Representative Matthew Blumenthal SENATORS: Kissel, Bizzarro, Flexer, Haskell, Lesser, McCrory, Sampson, REPRESENTATIVES: Rebimbas, Carpino, Champagne, Cummings, Currey, Dillon, Dubitsky, Fishbein, Fox, Godfrey, Harding, Haskell, Hill, Horn, Luxenberg, McGorty, Miller, O'Dea, O'Neil, Palm, Porter, Riley, Walker, Young REP. BLUMENTHAL (147TH): I'm going to read the safety announcements. In the interest of safety I would ask you to note the location of and access to the exits in this hearing room. The two doors through which you entered the room are the emergency exits and are marked with exit signs. In the event of an emergency please walk quickly to the nearest exit. After exiting the room go to your right and exit the building by the main entrance or follow the exit signs to one of the other exits. Please quickly exit the building and follow any instructions from the Capital Police. Do not delay and do not return unless and until you are advised it is safe to do so. In the event of a lockdown announcement, please remain in the hearing room, stay away from the exit doors and seek concealment 2 MARCH 22, 2019 LRN JUDICIARY COMMITTEE 10:00 A.M. PUBLIC HEARING behind desks and chairs until an all-clear announcement is heard. So as you may have noticed, I am not Representative Stafstrom and I am not Senator Winfield, and you're going to notice that the attendance is a little bit sparser than usual on our side in the dais today. Rest assured that is not because we do not consider your testimony important; and in fact we have continued to hold this hearing out of respect for the public and the fact that we notice it and because you want your testimony. As you may have heard last Friday, a colleague of ours, Representative Ezekiel Santigo died suddenly and the funeral services are today so the Chairs and a number of the members of this Committee who were close with him are attending those services, but we wanted to continue with this hearing so we could get your testimony. Rest assured that all those who are not present for it will be viewing it on the television recording and we believe that Representative Santiago would not only understand but really value the fact that we are continuing with the legislative business that he considers so important. He was somebody raised in public service who spent a great amount of time serving the public, fighting fiercely for his city of Bridgeport and citizens and residents of the state of Connecticut. He was a giant of this building and he will be missed dearly. So I would ask respectfully that we all offer him a moment of silence. [Silence] Thank you, and we'll get started with the hearing. Before we get started I just wanted to talk briefly about the ground rules. I'm sure we're going to have some folks who feel very vigorously on both 3 MARCH 22, 2019 LRN JUDICIARY COMMITTEE 10:00 A.M. PUBLIC HEARING sides of this issue, or on all sides, probably more than two sides; but we'd ask that you treat the -- this hearing in the audience as if you were in a courtroom. There should be no demonstrations of support or disband for any of the people testifying here today. Please keep quiet unless you're testifying or unless you're addressed by members of the Committee out of respect for the proceeding and the public testimony we're going to hear. All right. We will get started. Our first witness will be Representative Candelora. REP. CANDELORA (86TH): Thank you, Mr. Vice-Chairman Blumenthal and Ranking Member Rebimbas and members of the Judiciary Committee. My name is Vincent Candelora testifying in opposition of I guess all the Bills on the agenda. And with me I have Dr. Kaminer from Yukon. He's a Doctor of Psychiatry Pediatrics and Dr. D'Souza from Yale University and I would like to just yield my time to them. DR. DEPAK D'SOUZA: Good morning and thank you for the opportunity to testify. I'm the Depak D'Souza. I'm a Professor of Psychiatry at Yale University and also a Staff Psychiatrist for the Connecticut Mental Health Center. I'm not just testifying on behalf of them, I'm testifying as an individual. I'm a psychiatrist for the last almost 30 years. I treat Veterans with serious mental illness. I also conduct research on cannabis and cannabinoid for the last 25 years. I'm also the father of a 17-year-old who is on the brink of adulthood and also drive on 95. And that basically summarizes the four main reason why I have concerns about -- about the Bill that's being discussed. 4 MARCH 22, 2019 LRN JUDICIARY COMMITTEE 10:00 A.M. PUBLIC HEARING The first is the impact of cannabis on the developing brain in young people and I'm going to turn over to my colleague, Dr. Yifrah who is actually working with a pediatrician and works in child psychiatry. So the first is the issue of cannabis on the developing brain. We have now mounting evidence from both animal studies and some limited gene studies suggesting that exposure to cannabis in adolescents can have far reaching effects. We also know that the acute effects of cannabis impair many important cognitive functions that are important for student life such as learning and memory. While this Bill is not going to allow the sale of cannabis from young people, we know from experience both with tobacco and alcohol and the experience in Colorado that there is a trickle-down effect that cannabis actually ends up with kids. And despite all the legislation, 90 percent of kids in Colorado who smoke cannabis actually get it from their parents, family members and friends. So we don't have a mechanism in place to actually prevent cannabis trickling down to children and young people. As you know, brain development continues until the age of 25, not 21 so I would urge the Committee to take that into consideration. The second issue is the issue of addiction. There is no question that cannabis is addictive like many other drugs that are common criteria that we have in the diagnoses and diagnostic and statistically manual, DSM5 which people in psychiatry use that people can tend to spend a lot of time, money, using marijuana, recovering from it, acquiring or attempting to quit it. We have done brain imaging studies here at Yale showing clearly that even once a day users of cannabis show reductions in -- in the 5 MARCH 22, 2019 LRN JUDICIARY COMMITTEE 10:00 A.M. PUBLIC HEARING number of cannabinoid receptors in the brain. About 20 percent of people who use regularly will develop a Cannabis Use Disorder and this is important for the Committee to know, there are no accepted treatments for Cannabis Use Disorder as yet. So it's conceivable that there would be an increase in the people seeking help for cannabis and we won't have anything to provide them treatment for. The third issue is driving. There is absolutely no question that both in experimental studies in the lab and field studies that cannabis impairs driving and impairs many of the cognitive functions that are critical to driving such as attention, memory, keeping track of distance and time, etc. And one's risk of getting into a motor vehicle accident is increased about two-fold when one is under the influence of cannabis. Unfortunately our law enforcement colleagues don't have the tools necessary to be able to evaluate people conclusively for exposure to cannabis or driving under the exposure of cannabis and the cost of a study done in 2017 showed that the cost of motor vehicle accidents in Canada was almost a billion dollars. I ask the question, who will pay for that care in the state of Connecticut? And the last point I would like to make -- REP. BLUMENTHAL (147TH): We'll just ask you to summarize. DR. DEPAK D'SOUZA: The last point I would like to make is the issue of the impact of cannabis on people with serious psychological illness such as schizophrenia and bipolar disorder. We know for sure that there's a negative impact on the -- on the exposure -- on cannabis exposure and serious mental 6 MARCH 22, 2019 LRN JUDICIARY COMMITTEE 10:00 A.M. PUBLIC HEARING illness such as schizophrenia and bipolar disorder including hospitalization, etc. We are already cutting down mental health services here in Connecticut. I would imagine that we would need to think about how we would manage paying for and providing services for those with serious mental illness who experience problems with cannabis. REP. BLUMENTHAL (147TH): Thank you. Are there questions from the Committee? SENATOR CHAMPAGNE (35TH): Are we going to hear from the other -- the other doctor? Can you please give us a brief on what you had to say? DR. YIFRAH KAMINER: My name is -- REP. BLUMENTHAL (147TH): Please use the microphone and please state your name for the record. Thank you. DR. YIFRAH KAMINER: Sure. Yifrah Kaminer, Professor of Psychiatry in Pediatrics at the University of Connecticut Health Center. I'm also Chairman of the Board of the Research Society of Marijuana and on the Scientific Advisory Board for Marijuana and Legalization. There are several other disorders Dr. D'Souza didn't have time to address.
Load more

Recommended publications
  • Tobacco & Cannabis
    TOBACCO & CANNABIS: THE EVOLUTION OF PERTINENT RULES & REGULATIONS AND SUBSEQUENT FINANCIAL RAMIFICATIONS by Virginia Palmer Yerger Avisto A thesis submitted to the faculty of The University of Mississippi in partial fulfillment of the requirements of the Sally McDonnell Barksdale Honors College. Oxford May 2016 Approved by _________________________ Advisor: Dr. Bonnie Van Ness _________________________ Reader: Dr. Travis Box _________________________ Reader: Dr. Dwight Frink © 2016 Virginia Palmer Yerger Avisto ALL RIGHTS RESERVED ii I would like to dedicate my thesis to all family members who encouraged me to apply to the Honors College and acted as my cheerleaders throughout the entire process. Peter Avisto Virginia Avisto Harrison Avisto Gingia Yerger Swan Yerger Patricia Avisto Uno Avisto iii ABSTRACT PALMER AVISTO: Tobacco & Cannabis: The Evolution of Pertinent Rules & Regulations and Subsequent Financial Ramifications (Under the direction of Dr. Bonnie Van Ness) My thesis will discuss the evolution of the regulations surrounding tobacco and cannabis and the subsequent financial ramifications later posed on pertaining companies and the industries themselves. I will also briefly discuss the evolution of tobacco advertisements and the introduction of e-cigarettes into the tobacco market. Concerning newly legalized cannabis stores, I will discuss the struggle to acquire financial tools, the state-Federal disagreement, and proposed solutions to those issues. Both having been deemed “public enemy number one,” I will compare marijuana and tobacco regarding health effects, profitability after new laws, and their overall economic profitability for the country. I researched and summarized all pertinent regulations for the two industries and analyzed the available annual reports for the major tobacco companies.
    [Show full text]
  • The Impact of Cannabis Access Laws on Opioid Prescribing
    Journal of Health Economics 69 (2020) 102273 Contents lists available at ScienceDirect Journal of Health Economics j ournal homepage: www.elsevier.com/locate/econbase The impact of cannabis access laws on opioid prescribing a,∗ b c Benjamin J. McMichael , R. Lawrence Van Horn , W. Kip Viscusi a Assistant Professor of Law, University of Alabama School of Law, Box 870382, 101 Paul W. Bryant Drive East, Tuscaloosa, AL, 35487, United States b Associate Professor of Management and Law, Executive Director of Health Affairs, Owen Graduate School of Management, Vanderbilt University, 401 21st Avenue South, Nashville, TN, 37203, United States c University Distinguished Professor of Law, Economics, and Management, Vanderbilt University Law School. 131 21st Avenue South, Nashville, TN, 37203, United States a r a t i c l e i n f o b s t r a c t Article history: While recent research has shown that cannabis access laws can reduce the use of prescrip- Received 5 October 2018 tion opioids, the effect of these laws on opioid use is not well understood for all dimensions Received in revised form 17 July 2019 of use and for the general United States population. Analyzing a dataset of over 1.5 bil- Accepted 7 December 2019 lion individual opioid prescriptions between 2011 and 2018, which were aggregated to the Available online 14 December 2019 individual provider-year level, we find that recreational and medical cannabis access laws reduce the number of morphine milligram equivalents prescribed each year by 11.8 and 4.2 JEL classification: percent, respectively. These laws also reduce the total days’ supply of opioids prescribed, I180 the total number of patients receiving opioids, and the probability a provider prescribes K19 any opioids net of any offsetting effects.
    [Show full text]
  • A Baseline Review and Assessment of the Massachusetts Adult-Use Cannabis Industry: Market Data and Industry Participation
    A Baseline Review and Assessment of the Massachusetts Adult-Use Cannabis Industry: Market Data and Industry Participation February 2020 Massachusetts Cannabis Control Commission: Steven J. Hoffman, Chairman Kay Doyle, Commissioner Jennifer Flanagan, Commissioner Britte McBride, Commissioner Shaleen Title, Commissioner Shawn Collins, Executive Director Prepared by the Massachusetts Cannabis Control Commission Research and Information Technology Departments: Samantha M. Doonan, BA, Research Analyst David McKenna, PhD, Chief Technology Officer Julie K. Johnson, PhD, Director of Research Acknowledgements External Collaborators Alexandra F. Kritikos, MA, Brandeis University Cannabis Control Commission Communications Cedric Sinclair, Director of Communications Maryalice Gill, Press Secretary Kirsten Swenson, Communications Specialist Management Alisa Stack, Chief Operating Officer Erika Scibelli, Chief of Staff Legal Christine Baily, General Counsel Allie DeAngelis, Associate General Counsel Enforcement and Licensing Yaw Gyebi, Chief of Enforcement Paul Payer, Enforcement Counsel Kyle Potvin, Director of Licensing Patrick Beyea, Director of Investigations Derek Chamberlin, Licensing Analyst Anne DiMare, Licensing Specialist Government Affairs David Lakeman, Director of Government Affairs 2 Suggested bibliographic reference format: Doonan SM., McKenna, D., Johnson JK., (2020, February). A Baseline Review and Assessment of the Massachusetts Adult-Use Cannabis Industry— A Report to the Massachusetts Legislature. Boston, MA: Massachusetts Cannabis
    [Show full text]
  • The Forensic Identification of Marijuana: Suspicion, Moral Danger, and the Creation Of
    Title: The Forensic Identification of Marijuana: Suspicion, Moral Danger, and the Creation of Non-Psychoactive THC Author: Aaron Roussell* Running Head: “Marijuana Identification” Abstract: Federal and state laws present marijuana as a dangerous substance requiring coercive control and forbid private citizens from possessing, selling, or growing it. Possession cases brought under these laws depend on a forensic confirmation of taxonomic identity as Cannabis sativa to establish and successfully prosecute a case. Hemp Industries Association v. DEA (2003), a recent federal appeals court ruling, is at odds with this forensic process. American citizens may legally possess and even consume a similar substance — hemp and its derivatives — which can be made into such everyday objects as clothing, rope, and food products. Yet these two plants are both Cannabis sativa and differ only in physical structure and degree of natural tetrahydrocannabinol (THC). Synthetic THC is also a medically prescribed substance, which introduces further confusion into the legal standing of cannabis. Finally, *Department of Criminology, Law & Society, University of California, Irvine. Address correspondence to Aaron Roussell, Department of Criminology, Law & Society, University of California, Irvine, Social Ecology II, Irvine, CA 92697; email: [email protected]. 949-943-9860 Thanks to Professors Simon Cole, Justin Richland, Michael Clegg, and Dr. Fred Whitehurst for their direct or indirect contributions and assistance, as well as Akhila Ananth, Vivek Mittal, and Trish Goforth for their help with paper drafts and the editorial staff of the Albany Law Journal of Science and Technology for their superb efforts to improve the final version. Mistakes and weaknesses herein are entirely in spite of their efforts and remain the sole dominion of the author.
    [Show full text]
  • CSBS Cannabis Job Aid
    16 September 2021 CSBS Cannabis Job Aid CSBS Cannabis Job Aid Industrial hemp was legalized federally by the 2018 Farm Bill. States across the country are now establishing regulatory schemes for hemp production. The job aid is an examiner reference tool providing background as well as state-specific information, such as legalization status and related topics, on both hemp and marijuana. As federal and state cannabis laws change, we expect that frequent updates will be necessary to keep this job aid up to date. The CSBS State Supervisory Processes Committee approved the release of this job aid to assist state examiners in the examination of a financial institution that may be banking cannabis-related businesses. If you notice something in the job aid that needs to be edited contact Daniel Berkland ([email protected]). Table of Contents Hemp Job Aid .............................................................................................................................................................................................. 2 Marijuana Job Aid .................................................................................................................................................................................... 13 State by State Cannabis Policy ................................................................................................................................................................. 28 Territory Cannabis Policy ........................................................................................................................................................................
    [Show full text]
  • Investing in the Legal U.S. Cannabis Market
    INVESTING IN THE LEGAL U.S. CANNABIS MARKET WHITE PAPER OCTOBER 2019 PETE KARABAS • TIBY ERDELY • JORDAN YOUKILIS FOUNDING PARTNERS OF KEY INVESTMENT PARTNERS LLC P a g e | 1 Table of contents Executive summary .............................................................................................................................................................................. 2 Section 1: Cannabis 101 ........................................................................................................................................................................ 3 Section 2: Projected growth of the cannabis market ..................................................................................................................... 7 Section 3: The politics of cannabis in the U.S. .............................................................................................................................. 11 Section 4: Unique characteristics of the cannabis industry as an investment opportunity ............................................... 16 Section 5: The public cannabis markets ......................................................................................................................................... 19 Section 6: Investors in ancillary businesses can avoid several risks that plant-touching investors will face today .... 23 Section 7: Conclusion .........................................................................................................................................................................
    [Show full text]
  • Lead to Higher Rents? an Estimation of the Effects of Cultivation Laws on Colorado Industrial Property Values
    ABSTRACT DOES A LEGAL “HIGH” LEAD TO HIGHER RENTS? AN ESTIMATION OF THE EFFECTS OF CULTIVATION LAWS ON COLORADO INDUSTRIAL PROPERTY VALUES by Jack Edward Fetick This paper analyzes the effect of a change in the legal status of cannabis cultivation on the value of industrial space. An often-cited positive impact of legalization is the increase in tax revenue to the state, yet an increase in demand for warehouse-like spaces may crowd out other industries. An initial estimation analyzes how different characteristics of Colorado counties affect ballot choices. The results indicate areas that supported Barack Obama in 2012 were 26-37 percent more likely to support legalized cannabis. I then estimate the effect of municipalities exercising a “local option” to ban cannabis production on the values of industrial spaces. The natural variation of the local option across the state is used to compare industrial space values across treated areas using a difference-in-differences design. Using data from real estate listing website LoopNet, this paper estimates a slightly higher difference in the value of industrial space in areas with legal cultivation status. DOES A LEGAL “HIGH” LEAD TO HIGHER RENTS? AN ESTIMATION OF THE EFFECTS OF CULTIVATION LAWS ON COLORADO INDUSTRIAL PROPERTY VALUES Thesis Submitted to the Faculty of Miami University in partial fulfillment of the requirements for the degree of Master of Arts by Jack Edward Fetick Miami University Oxford, Ohio 2018 Advisor: Dr. Melissa Thomasson Reader: Dr. Analisa Packham Reader: Dr. Austin Smith ©2018 Jack Edward Fetick This thesis titled DOES A LEGAL “HIGH” LEAD TO HIGHER RENTS? AN ESTIMATION OF THE EFFECTS OF CULTIVATION LAWS ON COLORADO INDUSTRIAL PROPERTY VALUES by Jack Edward Fetick has been approved for publication by Farmer School of Business and Department of Economics _______________________________________ Dr.
    [Show full text]
  • What Canadian Youth Think About Cannabis: Report in Short
    www.ccsa.ca • www.cclt.ca What Canadian Youth Think about Cannabis Report in Short The Issue Canadian youth are the top users of cannabis in the developed world.1 Despite a decrease in cannabis use among youth in recent years,2 cannabis remains the most commonly used illegal drug among Canadian youth, 15- 24 years of age.3 In fact, the number of youth who have used cannabis within the last year is currently three times higher than that of adults aged 25 years and older (21.6% vs. 6.7%).3 In some Canadian jurisdictions, approximately 50% of grade 12 students have reported consuming cannabis within the last year.4 Although cannabis can produce feelings of euphoria and relaxation, its use can lead to negative consequences. Short-term use can cause difficulties in brain functions such as memory, perception of time, coordination and balance.5 These effects can lead to injuries or car crashes when driving.6 In addition to health and safety concerns, youth substance abuse can also lead to difficulties at school and problems with relationships and the law.7 Adolescents are particularly at risk for cannabis related harms since their brains are undergoing rapid and extensive development. Research tells us that chronic cannabis use is associated with memory, thinking and attention difficulties, particularly among those who began using cannabis in early adolescence.8 Chronic use might also increase the risk of psychosis, depression and anxiety, in addition to respiratory conditions and possibly lung cancer.9,10,11,12 Although there is an increasing amount of knowledge related to the harms linked to cannabis use, we know little about what youth think about the drug and what influences their decisions to use it.
    [Show full text]
  • How Small Cannabis Businesses Can Survive the Hurdles of IP Protection
    Texas A&M Law Review Volume 8 Issue 1 11-1-2020 How Small Cannabis Businesses Can Survive the Hurdles of IP Protection Spencer Keller Texas A&M University School of Law (Student), [email protected] Follow this and additional works at: https://scholarship.law.tamu.edu/lawreview Part of the Intellectual Property Law Commons, and the Weed Science Commons Recommended Citation Spencer Keller, How Small Cannabis Businesses Can Survive the Hurdles of IP Protection, 8 Tex. A&M L. Rev. 199 (2020). Available at: https://doi.org/10.37419/LR.V8.I1.6 This Comment is brought to you for free and open access by Texas A&M Law Scholarship. It has been accepted for inclusion in Texas A&M Law Review by an authorized editor of Texas A&M Law Scholarship. For more information, please contact [email protected]. \\jciprod01\productn\T\TWL\8-1\TWL106.txt unknown Seq: 1 16-OCT-20 11:49 COMMENT HOW SMALL CANNABIS BUSINESSES CAN SURVIVE THE HURDLES OF IP PROTECTION by: Spencer Keller* ABSTRACT The current state of cannabis and intellectual property laws and regulations leaves small and emerging cannabis businesses at a distinct disadvantage com- pared to those in other industries. Those wishing to pursue cannabis inven- tions and patents face an uphill battle as cannabis research and development is nearly impossible to conduct legally. The difficulty in researching cannabis has pushed companies to move their research outside of the United States, leaving those growing businesses unable to corner their market in the cannabis industry. Complicating matters further are the overly broad patents that can- nabis patentees are likely receiving as a result of market participants leaving innovations undocumented due to fear of being prosecuted for their involve- ment in the industry.
    [Show full text]
  • Cannabis Legalization and Criminal Justice Reform
    March 17, 2021 High crimes and misdemeanors: Cannabis legalization and criminal justice reform By Travis Hill New York State is on the cusp of legalizing cannabis for recreational use. Will it have the social and economic impact many legislators and advocacy groups hope for? Initially put forth in the 2019 legislative session, legalizing recreational marijuana took a backseat to more wide-ranging criminal justice reforms, as New York overhauled state bail and discovery practices. Now that those initial reforms have been implemented, legalizing marijuana has once again taken center stage as a way to address past wrongs and make the criminal justice system more equitable. Currently, there are two marijuana bills pending before the state legislature. One is the stand-alone Marijuana Regulation and Taxation Act (MRTA) and the other is the Cannabis Regulation and Taxation Act (CRTA), which the governor included in the FY2022 executive budget. Both bills seek to legalize adult recreational use of marijuana and provide an economic boost to communities disproportionately impacted by the decades-long war on drugs. If either bill becomes law, New York will follow closely on the heels of its neighbor New Jersey, which earlier this year legalized cannabis possession and use for adults age 21 and older (A21 – The New Jersey Cannabis Regulatory, Enforcement Assistance, and Marketplace Modernization Act). Similar to New Jersey, the New York bills provide for a heavy regulatory framework, reinvestment in communities disproportionately impacted by the failed war on drugs, and criminal justice reforms. The competing New York bills are closely aligned in their stated goals; however, they have some key differences in achieving the primary policy objectives of legalization and economic developm ent.
    [Show full text]
  • GREEN THUMB INDUSTRIES INC. (Exact Name of Registrant As Specified in Its Charter)
    Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10/A AMENDMENT NO. 2 GENERAL FORM FOR REGISTRATION OF SECURITIES PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 GREEN THUMB INDUSTRIES INC. (Exact name of registrant as specified in its charter) British Columbia 98-1437430 (State or other jurisdiction of (I.R.S. employer incorporation or organization) identification no.) 325 West Huron Street, Suite 412 Chicago, Illinois 60654 (Address of principal executive offices and zip code) (312) 471-6720 (Registrant’s telephone number, including area code) Securities to be registered pursuant to Section 12(b) of the Act: None Securities to be registered pursuant to Section 12(g) of the Act: Subordinate Voting Shares Multiple Voting Shares Super Voting Shares (Title of class) Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☒ Smaller reporting company ☐ Emerging growth company ☒ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financing accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Table of Contents TABLE OF CONTENTS Page IMPLICATIONS OF BEING AN EMERGING GROWTH COMPANY 1 DISCLOSURE REGARDING FORWARD-LOOKING STATEMENTS 2 ITEM 1.
    [Show full text]
  • JUD Committee Hearing Transcript for 02/26/2021
    1 FEBRUARY 26, 2021 rr/si JUDICIARY COMMITTEE 10:00 A.M. CHAIRPERSONS: Senator Gary Winfield, Representative Steve Stafstrom SENATORS: Anwar, Bradley, Champagne, Haskell, Kasser, Kissel, Lesser, Sampson, Winfield, REPRESENTATIVES: Blumenthal, Callahan, Conley, Currey, Dillon, Doucette, Dubitsky, Fiorello, Fishbein, Fox, Godfrey, Harding, Howard, Labriola, Luxenberg, Miller, O'Dea, Palm, Porter, Quinn, Rebimbas, Riley, Simms, Veach, Walker, Young, Candelora REP. STAFSTROM (129TH): Good morning, everyone. I'd like to call to order the Judiciary Committee Public Hearing for February 26, 2021. We have one item on our agenda today. And that's Senate Bill 888, which is AN ACT RESPONSIBLY AND EQUITABLY REGULATING ADULT-USE CANNABIS. It is a Governor's Bill that is before us today. And I know we have a number of folks in the administration here with us. So, we're going to start there. Before we do though, I just want to remind the Committee that we have nearly 150 people who are signed up to testify today at three minutes a pop, that's seven and a half hours of testimony straight through without any questions or delays or the like. I would ask the Committee today so that we can get to hear from the public sooner rather than later that if you have questions, that they be brief, they be direct, and they be to the point and they not be repetitive. I understand members may be in and out of this Committee and other Committees today, that's fine. But for the interest of the public, and for those who are testifying, if you've missed something, we can go back and watch it, or we can follow up, particularly with the administration 2 FEBRUARY 26, 2021 rr/si JUDICIARY COMMITTEE 10:00 A.M.
    [Show full text]